Mannkind CORP Form 4 insider transactions

Stuart A. Tross, Chief People & Workplace Officer at MannKind Corp, reports a transaction involving common stock due to tax liability.

Michael Castagna, CEO of MannKind Corp, reports a transaction involving the withholding of shares to cover tax liabilities.

Director Steven B. Binder of MannKind Corp reports the disposition of shares, including those under a Rule 10b5-1 plan.

David Thomson, EVP, General Counsel & Secretary of MannKind Corp, sold 2,345 shares of common stock at an average price of $4.41, following a transaction to cover tax liabilities.

MannKind Corporation's CEO, Michael Castagna, acquired 27,000 shares of common stock at $4.56 per share through the company's Market Price Stock Purchase Plan.

Dominic Marasco, President of the Endocrine Business Unit at MannKind Corp, reports acquisition of shares through a restricted stock unit award and a market price stock purchase plan.

Director Anthony Hooper reports acquiring 25,000 shares of MannKind Corp common stock and restricted stock units.

Director James Samuel Shannon reports acquiring 52,854 restricted stock units in MannKind Corp on May 14, 2025.

Director Jennifer Grancio reports acquisition of 52,854 restricted stock units in MannKind Corp, convertible to common stock upon separation of service.

Director Christine Mundkur reports acquisition of 52,854 restricted stock units in MannKind Corp, convertible to common stock upon separation of service.

Director Michael A. Friedman reports acquisition of 52,854 restricted stock units in MannKind Corp.

Director Ronald J. Consiglio acquired 52,854 restricted stock units in MannKind Corp on May 14, 2025, which will vest upon separation of service from the board.

Director Sabrina Kay acquired restricted stock units in MannKind Corp (MNKD) on May 14, 2025, which will vest but shares will be delivered upon separation of service from the board.

David Thomson, EVP, General Counsel & Secretary of MannKind Corp, reports transactions involving common stock and restricted stock units, including vesting of performance-based RSUs and sales under a 10b5-1 plan.

Director Steven B. Binder reports acquisition and disposal of MannKind Corporation stock related to the vesting of restricted stock units and tax obligations.

Stuart A. Tross, Chief People & Workplace Officer at MannKind Corp, reports acquisition and disposal of shares related to vesting of restricted stock units (RSUs) and tax obligations.

Michael Castagna, CEO of MannKind Corp, reports acquisition and disposal of shares related to vesting of restricted stock units (RSUs) and tax obligations.

EVP Technical Operations Sanjay R Singh reports acquiring 119,000 shares of MannKind Corp common stock and 145,000 performance-based restricted stock units.

Christopher Prentiss, CFO of MannKind Corp, reports acquiring 119,000 shares of common stock and 145,000 performance-based restricted stock units.

Michael Castagna, CEO of MannKind Corp, reports the transfer of 39,500 shares of MNKD common stock to his ex-spouse as part of a divorce settlement.

EVP Operations Lauren Sabella reports disposition of MannKind Corp shares to cover income tax obligations related to vesting restricted stock units.

Christopher Prentiss, CFO of MannKind Corp, amended a previous SEC filing to correct the vesting schedule of restricted stock units.

Dominic Marasco, President of the Endocrine Business Unit at MannKind Corp, reports acquiring 252,000 shares of common stock on February 12, 2025.

Steven B. Binder, a director at MannKind Corp, exercised stock options and sold shares on November 22, 2024, under a pre-arranged 10b5-1 trading plan.

Director Steven B. Binder exercised stock options and sold shares of MannKind Corp common stock, according to a recent SEC filing.

Stuart A. Tross, Chief People & Workplace Officer of MannKind Corp, sold 55,000 shares of common stock at a price of $7.34 per share on November 6, 2024, according to a Form 4 filing with the SEC.

EVP Technical Operations Sanjay R Singh sold shares of MannKind Corp to cover income tax obligations related to vesting restricted stock units.

Stuart A. Tross, Chief People & Workplace Officer of MannKind Corp, sold 25,000 shares of common stock at an average price of $6.26 on September 3, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Stuart A. Tross, Chief People & Workplace Officer of MannKind Corp, sold 80,000 shares of common stock on August 30, 2024, under a pre-arranged 10b5-1 trading plan.

Michael Castagna, CEO of MannKind Corp, reports the disposition of shares for tax obligations and charitable donations, along with a sale of shares on August 29, 2024.